# Amgen Inc. – FDA Inspection, Nov 6, 2025

Source: https://www.keypedia.com/records/fda_inspections/amgen-inc/fa1bdcd1-cd95-435e-a357-cacef4563079
Source feed: FDA_Inspections

> FDA inspection 1293010 of Amgen Inc., November 06, 2025. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1293010
- Company Name: Amgen Inc.
- Inspection Date: 2025-11-06
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1234412 - 2024-07-30

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/burnell-m-henry/dece4407-3597-4a58-8756-5abf9db43bbc)

Company: https://www.keypedia.com/companies/amgen-inc/ebaa268e-d67a-4623-8e1b-ed5f19dbbf2b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d